Business Wire

CA-SCIENTIST.COM

9.2.2021 13:57:10 CET | Business Wire | Press release

Share
Daniel Kagan Promoted to President at Scientist.com

Scientist.com, the healthcare industry’s leading marketplace for life science research, announced today the promotion of Daniel Kagan, PhD, to President. In his new role, Dan will launch and grow Scientist.com’s new AI-powered biotech-as-a-serviceTM (BaaS) platform and continue to lead the company’s operations and strategic partnering efforts.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210209005120/en/

“Dan has played a critical role in Scientist.com’s meteoric rise over the last six years, touching nearly every aspect of the organization,” said Kevin Lustig, PhD, Scientist.com’s CEO. “His exceptional leadership, clear-sighted vision and legendary work ethic have helped the company take huge steps toward achieving its mission to empower scientists and make it possible to cure all human diseases by 2050.”

Dan joined Scientist.com in 2013 after an award-winning PhD from UC San Diego’s powerhouse bioengineering program. As the company’s Vice President of Research and then Chief Operating Officer, he has played a pivotal role in building Scientist.com into one of the country’s fastest-growing private companies (peaking at #9 on the Inc. 500 list in 2018). Under his leadership, year over year sales have increased for 73 straight months, from $11M USD in 2015 to $265M USD in 2020. Dan has also worked tirelessly to foster a vibrant, close-knit and hard-working culture that is the secret sauce behind the company’s success. His commitment to fostering and growing new leadership within Scientist.com has resulted in very low employee turnover. Reflecting his efforts, the company was recognized by Inc. magazine in 2018 and 2019 as one of “America’s Best Workplaces.”

About Scientist.com

Scientist.com is the pharmaceutical industry’s leading AI-powered marketplace for outsourced R&D. The marketplace simplifies R&D sourcing, saves time and money, reduces risk and provides access to the latest innovative tools and technologies. Scientist.com operates private enterprise marketplaces for most of the world’s major pharmaceutical companies, over 80 biotechnology companies, the Biotechnology Innovation Organization (BIO) and the US National Institutes of Health (NIH).

Visit scientist.com to learn more.

Join Scientist.com on social media: LinkedIn , Twitter , YouTube , Facebook and Instagram

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

KŌZĒ Stays Launches International Expansion with More Than 1,200 Properties18.11.2026 14:28:00 CET | Press release

The Canadian hospitality brand expands its collection across more than 33 countries and more than 500 cities, introducing exclusive member privileges through KŌZĒ Privé. KŌZĒ Stays announces a major international expansion, bringing its curated portfolio to more than 1,200 properties worldwide. Following eight consecutive years of rapid growth, the company is building on its established presence in Mont-Tremblant and the Laurentians to pursue a broader ambition in international hospitality. The expanded collection spans French and Swiss alpine chalets, Riviera villas near Monaco, Lake Como residences, private retreats in St. Barths and homes on Dubai’s Palm Jumeirah. Available through The KŌZĒ Collection, these properties extend the brand’s reach into some of the world’s most sought-after destinations. Canadian Roots, International Ambition “A guest who loves their stay with us in Mont-Tremblant should be able to book their next trip, whether that’s Verbier, St. Barths or Lake Como, kn

Blue Yonder Announces New Leadership18.11.2026 14:03:00 CET | Press release

CTO Salil Joshi Named Interim CEO to Lead Next Phase of Growth with Accelerated Innovation and Expanded Use of Company’s Technology Blue Yonder, the AI company for supply chain, today announced that Salil Joshi has been named interim Chief Executive Officer. Joshi has most recently served as Blue Yonder’s Chief Technology Officer, where he led the company’s technology vision and growth strategy across the digital supply chain. Joshi succeeds Duncan Angove, who will transition out of the CEO role after four years leading the company. The Blue Yonder Board appreciates the contributions that Angove has made to the company. “Blue Yonder continues to showcase strong momentum through accelerating Cognitive Solutions adoption in the market. Blue Yonder has reported impressive SaaS ARR growth, adding new customer logos and increasing inclusions in key tech and industry analyst reports,” said Ken Sain, Chairman of the Blue Yonder Board of Directors and CEO of Panasonic Connect Group. “We believ

AI Private Markets Platform FinBursa Appoints Angelica Tigan as Chief Revenue Officer to Drive US and Global Growth18.11.2026 14:00:00 CET | Press release

Former BlackRock and eFront sales leader joins the agentic AI front office FinBursa, the intelligent front office for private markets, has appointed Angelica Tigan, a former BlackRock and eFront sales leader, as Chief Revenue Officer to lead its global commercial expansion following the launch of FinBursa 360. Based in the US, Tigan will lead sales and partnerships worldwide, with an immediate focus on the US. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261118596329/en/ Angelica Tigan, based in New York City, joins FinBursa as Chief Revenue Officer Tigan brings close to two decades in private markets technology, having built, led and scaled sales teams at BlackRock (Aladdin) and eFront, with previous experience at Intralinks and Gen II Fund Services. FinBursa 360 is an all-in-one platform for private equity, private credit, real estate, venture capital and M&A advisory firms, family offices, wealth managers, placement age

Scientist.com Launches Pharma Observatory, an Agent-First Market Intelligence Platform for Biopharma R&D18.11.2026 13:55:00 CET | Press release

Puts every trial, drug, company, investigator and patent in one cross-referenced model, built for AI agents from day one, with simple published pricing Scientist.com, the leading AI-enabled R&D orchestration platform and marketplace for the life science industry, today announced the launch of Pharma Observatory, a market intelligence platform that shows biopharma teams where their programs sit in the wider market. Scientist.com helps research teams drive a project forward. Pharma Observatory places that project in context: who else is working on the same target or indication, who the likely partners and acquirers are, and what the eventual clinical trials are likely to look like. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261118907460/en/ Scientist.com's Pharma Observatory brings nearly 1 billion records from ~100 public sources (ClinicalTrials.gov, FDA, USPTO, NIH, SEC) into one cross-referenced model. The public record

Helical Fusion Awarded Up to JPY 19.2 Billion in Japanese Government Funding to Accelerate Commercial Fusion Power18.11.2026 13:36:00 CET | Press release

Bringing together Japan’s fusion research and manufacturing expertise to advance commercial fusion Helical Fusion Co., Ltd., a fusion energy company developing commercially viable power plants based on Helical Stellarator technology, has been formally selected for a major Japanese government grant program administered by the Ministry of Economy, Trade and Industry (METI). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261118128278/en/ The maximum government subsidy is approximately JPY 19.2 billion (USD 126 million). The grant-supported project is scheduled to run through February 2029. Through the Helix Program, Helical Fusion leads overall plant design and systems integration, drawing on research from Japan’s national research institutions and the engineering and manufacturing expertise of approximately 40 companies in Japan. The program aims to turn Japan’s scientific and industrial strengths into practical fusion power.

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye